Here’s What You Need to Know About Getting the New 2024 COVID Vaccine
The new COVID vaccine is here, but does it bring any new side effects or reactions? Here's what the COVID booster 2024 side ...
As new COVID-19 strains emerge, how do vaccine manufacturers keep up with mutations of the virus?
New COVID-19 strains are emerging and with it the need for updated vaccines to protect people from the virus. So how do ...
devdiscourse5d
Patent Wars: GSK Takes on Moderna Over mRNA Innovations
GlaxoSmithKline has filed lawsuits against Moderna in a Delaware federal court, alleging infringement of patents related to ...
pharmaphorum5d
GSK turns its guns on Moderna in mRNA jab patent dispute
The Mandl team was originally employed by Novartis, but GSK acquired rights to their work and intellectual property when it ...
NOLA.com7d
Don't call them boosters: Here's what to know about the flu and COVID vaccines this fall
Flu season is emerging and, although the disease is not predicted to be as prominent as years past, doctors urge people to ...
Investing6d
Moderna target cut to $55 on lowered guidance, competition concerns
In addition, the company's updated COVID-19 vaccine, SPIKEVAX®, has ... firms have revised their outlooks on Moderna. Piper Sandler reduced its target for Moderna to $115 from $157, maintaining ...
Moderna (MRNA) Receives a Hold from Jefferies
Jefferies analyst Michael Yee maintained a Hold rating on Moderna (MRNA – Research Report) today and set a price target of $55.00. The ...
Is Moderna, Inc. (MRNA) the Most Promising Biotech Stock According to Hedge Funds?
We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds. In this article, we are going ...
CDC chief pitches COVID-19, flu vaccines during Cleveland visit; here’s what to know about shots & a new at-home test
The CDC is attempting to get the COVID-19 shot into more arms by asking physicians and pharmacists to recommend the updated ...